Ulrik C Winsløw1, Line Rode2, Børge G Nordestgaard3. 1. Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 2. Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 3. Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark and Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Boerge.Nordestgaard@regionh.dk.
Abstract
BACKGROUND: Conflicting evidence has been found regarding the association between high tobacco consumption and body weight among smokers. We tested the hypothesis that high tobacco consumption is causally associated with low body weight. METHODS: We conducted a Mendelian randomization study with a genetic variant in CHRNA3 (rs1051730) as proxy for high tobacco consumption. The cohort consisted of 80,342 participants from the Copenhagen General Population Study, with details on body weight, smoking habits and CHRNA3 genotype, including 15,220 current smokers. RESULTS: In observational analyses, high tobacco consumption was associated with high body weight, body mass index, waist circumference, hip circumference and waist-hip ratio. In multivariable adjusted models a 1-cigarette/day higher tobacco consumption was associated with 0.05 kg (95% confidence interval 0.02; 0.08) higher body weight, 0.02 kg/m(2) (0.01; 0.02) higher body mass index, 0.10 cm (0.07; 0.12) higher waist circumference and 0.02 cm (0.001; 0.03) higher hip circumference. In contrast, the per-allele increase inCHRNA3 rs1051730 associated with high tobacco consumption was associated with 0.59 kg (0.96; 0.22) lower body weight, 0.23 kg/m(2) (0.33; 0.13) lower body mass index, 0.32 cm (0.74; 0.003) lower waist circumference and 0.45 cm (0.66; 0.24) lower hip circumference. No association was found between tobacco consumption and waist-hip ratio in genetic analysis, or among CHRNA3 genotype and any of the outcome variables in former or never smokers. CONCLUSIONS: High tobacco consumption causes lower body weight among current smokers. However, smoking does not seem to affect body shape or fat distribution causally. The lack of association between CHRNA3 genotype and body weight among former smokers and never smokers favours smoking as the causal factor for the observed associations.
BACKGROUND: Conflicting evidence has been found regarding the association between high tobacco consumption and body weight among smokers. We tested the hypothesis that high tobacco consumption is causally associated with low body weight. METHODS: We conducted a Mendelian randomization study with a genetic variant in CHRNA3 (rs1051730) as proxy for high tobacco consumption. The cohort consisted of 80,342 participants from the Copenhagen General Population Study, with details on body weight, smoking habits and CHRNA3 genotype, including 15,220 current smokers. RESULTS: In observational analyses, high tobacco consumption was associated with high body weight, body mass index, waist circumference, hip circumference and waist-hip ratio. In multivariable adjusted models a 1-cigarette/day higher tobacco consumption was associated with 0.05 kg (95% confidence interval 0.02; 0.08) higher body weight, 0.02 kg/m(2) (0.01; 0.02) higher body mass index, 0.10 cm (0.07; 0.12) higher waist circumference and 0.02 cm (0.001; 0.03) higher hip circumference. In contrast, the per-allele increase inCHRNA3 rs1051730 associated with high tobacco consumption was associated with 0.59 kg (0.96; 0.22) lower body weight, 0.23 kg/m(2) (0.33; 0.13) lower body mass index, 0.32 cm (0.74; 0.003) lower waist circumference and 0.45 cm (0.66; 0.24) lower hip circumference. No association was found between tobacco consumption and waist-hip ratio in genetic analysis, or among CHRNA3 genotype and any of the outcome variables in former or never smokers. CONCLUSIONS: High tobacco consumption causes lower body weight among current smokers. However, smoking does not seem to affect body shape or fat distribution causally. The lack of association between CHRNA3 genotype and body weight among former smokers and never smokers favours smoking as the causal factor for the observed associations.
Authors: Robert Carreras-Torres; Philip C Haycock; Caroline L Relton; Richard M Martin; George Davey Smith; Peter Kraft; Chi Gao; Shelley Tworoger; Loïc Le Marchand; Lynne R Wilkens; Sungshim L Park; Christopher Haiman; John K Field; Michael Davies; Michael Marcus; Geoffrey Liu; Neil E Caporaso; David C Christiani; Yongyue Wei; Chu Chen; Jennifer A Doherty; Gianluca Severi; Gary E Goodman; Rayjean J Hung; Christopher I Amos; James McKay; Mattias Johansson; Paul Brennan Journal: Sci Rep Date: 2016-08-04 Impact factor: 4.379
Authors: Eeva-Liisa Tuovinen; Suoma E Saarni; Satu Männistö; Katja Borodulin; Kristiina Patja; Taru H Kinnunen; Jaakko Kaprio; Tellervo Korhonen Journal: Prev Med Rep Date: 2016-07-11
Authors: Glenda Lassi; Amy E Taylor; Nicholas J Timpson; Paul J Kenny; Robert J Mather; Tim Eisen; Marcus R Munafò Journal: Trends Neurosci Date: 2016-11-18 Impact factor: 13.837
Authors: S Stenholm; J Head; V Aalto; M Kivimäki; I Kawachi; M Zins; M Goldberg; L G Platts; P Zaninotto; L L Magnusson Hanson; H Westerlund; J Vahtera Journal: Int J Obes (Lond) Date: 2017-01-31 Impact factor: 5.095
Authors: Robert Carreras-Torres; Mattias Johansson; Philip C Haycock; Kaitlin H Wade; Caroline L Relton; Richard M Martin; George Davey Smith; Demetrius Albanes; Melinda C Aldrich; Angeline Andrew; Susanne M Arnold; Heike Bickeböller; Stig E Bojesen; Hans Brunnström; Jonas Manjer; Irene Brüske; Neil E Caporaso; Chu Chen; David C Christiani; W Jay Christian; Jennifer A Doherty; Eric J Duell; John K Field; Michael P A Davies; Michael W Marcus; Gary E Goodman; Kjell Grankvist; Aage Haugen; Yun-Chul Hong; Lambertus A Kiemeney; Erik H F M van der Heijden; Peter Kraft; Mikael B Johansson; Stephen Lam; Maria Teresa Landi; Philip Lazarus; Loïc Le Marchand; Geoffrey Liu; Olle Melander; Sungshim L Park; Gad Rennert; Angela Risch; Eric B Haura; Ghislaine Scelo; David Zaridze; Anush Mukeriya; Milan Savić; Jolanta Lissowska; Beata Swiatkowska; Vladimir Janout; Ivana Holcatova; Dana Mates; Matthew B Schabath; Hongbing Shen; Adonina Tardon; M Dawn Teare; Penella Woll; Ming-Sound Tsao; Xifeng Wu; Jian-Min Yuan; Rayjean J Hung; Christopher I Amos; James McKay; Paul Brennan Journal: PLoS One Date: 2017-06-08 Impact factor: 3.240
Authors: Wen Zhou; Geoffrey Liu; Rayjean J Hung; Philip C Haycock; Melinda C Aldrich; Angeline S Andrew; Susanne M Arnold; Heike Bickeböller; Stig E Bojesen; Paul Brennan; Hans Brunnström; Olle Melander; Neil E Caporaso; Maria Teresa Landi; Chu Chen; Gary E Goodman; David C Christiani; Angela Cox; John K Field; Mikael Johansson; Lambertus A Kiemeney; Stephen Lam; Philip Lazarus; Loïc Le Marchand; Gad Rennert; Angela Risch; Matthew B Schabath; Sanjay S Shete; Adonina Tardón; Shanbeh Zienolddiny; Hongbing Shen; Christopher I Amos Journal: Int J Cancer Date: 2020-09-23 Impact factor: 7.396